Characteristics and Alternative Treatment Outcomes of Antimalarial-Refractory Cutaneous Lupus Erythematosus

JAMA Dermatol. 2017 Sep 1;153(9):937-939. doi: 10.1001/jamadermatol.2017.1160.

Authors

Renee Fruchter¹, Drew J B Kurtzman², Mital Patel², Joseph Merola², Andrew G Franks Jr¹, Ruth Ann Vleugels², Alisa N Femia¹

Affiliations

¹ Ronald O. Perelman Department of Dermatology, New York University Langone Medical Center, New York, New York.
² Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Abstract

This review of medical records evaluates the characteristics and treatments of antimalarial-refractory cutaneous lupus erythematosus.

Publication types

Multicenter Study

MeSH terms

Adult
Antimalarials / therapeutic use*
Female
Follow-Up Studies
Humans
Lupus Erythematosus, Cutaneous / drug therapy*
Male
Retrospective Studies
Treatment Outcome

Substances

Antimalarials